This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Manufacturing deals dominate as China merger reviews rebound 9.8% in 2025

By MLex Staff ( January 30, 2026, 06:23 GMT | Insight) -- Manufacturing led all industries in China's 2025 merger reviews, accounting for 247 of 687 unconditionally approved cases, as the regulator recorded a 9.8 percent increase in total reviews compared to 2024, reversing the prior year's decline. The State Administration for Market Regulation released its 2025 merger review wrap-up, showing reviews rebounded to 706 cases after dropping to 643 in 2024 from 797 in 2023.Manufacturing led all industries in China's 2025 merger reviews, accounting for 247 of 687 unconditionally approved cases, as the regulator recorded a 9.8 percent increase in total reviews compared to 2024, reversing the prior year's decline....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login